Sponsored Symposia

5th International 4 Corners of Cardiology Meeting

Friday 7th February 2020 from 12:15 – 13:15

There will be a lunchtime symposium held by Aspen Australia on Friday 7th February 2020 from 12:15 – 13:15 in the Mayfair Room 2. Speaking at the symposium will be the Director of Cardiology at Barwon Health, A/Prof John Amerena. 

Dr John AmerenaA/Prof John Amerena
Improving clinical outcomes by reducing bleeding in patients with acute coronary syndromes – the role of fondaparinux

Trained in Melbourne, followed by four years in the United States at the University of Michigan. Over that period of time he worked in the fields of hypertension & hyperlipidaemia, before returning to Australia where he is now a Cardiologist at Barwon Health. He currently has appointments with Deakin University in the School of Medicine as well as the Department of Epidemiology and Preventative Medicine at Monash University. John is the director of the Geelong Cardiology Research Unit which is currently involved in many phase II – III clinical trials, as well as director of Cardiac Services at Geelong Private Hospital. While still involved in hypertension he has become involved in research in atherothrombosis, especially with respect to antithrombotic/antiplatelet therapies, particularly in the context of atrial fibrillation. Heart failure is a major interest, and he is also the Director of the Heart Failure Programme at Barwon Health. John is well published in these areas, as well as in many other areas of cardiovascular medicine.

Chairperson: Prof David Hare 

This symposium is sponsored by the 4 Corners of Cardiology Meeting Partner Aspen Australia. 

________________________________________________________________________________________________________

Saturday 8th February 2020 from 08:00 – 09:00

There will be a lunchtime symposium held by Novartis on Saturday 8th February 2020 from 08:00 – 09:00 in the Mayfair Room 2. 
Breakfast will be provided to all attendees.
Further details to be confirmed.

________________________________________________________________________________________________________

Saturday 8th February 2020 from 12:45 – 13:45

There will be a lunchtime symposium held by Boehringer Ingelheim on Saturday 8th February 2020 from 12:45 – 13:45 in the Mayfair Room 2. Speaking at the symposium will be Prof Andrew Sindone and A/Prof Michael d’Emden.

Prof Andrew Sindone
SGLT2i’s in the hands of Cardiologists – why and how?

Prof Andrew Sindone B. Med (Hons), MD, FRACP, FCSANZ is Director of the Heart Failure Unit and Department of Cardiac Rehabilitation, Concord Hospital and Cardiologist, Ryde Hospital with private practice in Eastwood and Westmead. Professor Sindone studied Medicine at the University of Newcastle and graduated with First Class Honours and the University Medal in 1987. He completed his Residency at Royal North Shore Hospital, Physicians’ Training at Concord Hospital, Cardiology Advanced Training at St. Vincent’s Hospital and Doctorate through University of NSW. He has been involved in research, teaching and improving the lives of those with cardiovascular disease for over twenty-seven years. He established the Heart Failure Unit at Concord Hospital with its Clinic, research, rehabilitation and outreach programs. He teaches medical students, junior doctors, General Practitioners and cardiologists. Professor Sindone has received multiple awards, Grants, has been Principal Investigator in over 35 international multicentre clinical trials, has presented over 85 research papers and continues to publish in cardiology. He is Co-Chair of the NSW Cardiovascular Expert Reference Group, was on the Scientific Committee for the World Congress of Cardiology, is co-author of the Australian Heart Failure Guidelines and is on over 35 pharmaceutical advisory boards. He is patron of multiple charities and supports the Italian Community with heart disease.

A/Prof Michael d’Emden
SGLT2i’s in the hands of Cardiologists – why and how?

Dr Michael d’Emden graduated from University of Tasmania in 1978.  He was a resident and registrar at the Princess Alexandra Hospital in Brisbane before moving to Royal Melbourne Hospital in 1983.  He obtained his fellowship in 1985, completed a PhD at University of Melbourne in 1988 before doing further studies at the University of Iowa. He is now the Director of the Department of Endocrinology and Diabetes, a Clinical Associated Professor of the University of Queensland and was the vice president of the Australian Diabetes Society 2013-2014. His major clinical interests are the association of diabetes with cardiovascular disease, and lipid metabolism.  He serves on many national advisory boards as well as being a member of the International Management committees of the FIELD, ASPEN and TNT studies. He was a principle Australian investigator of the EMPA-REG and DECLARE studies.

This symposium is sponsored by the 4 Corners of Cardiology Meeting Partner Boehringer Ingelheim and Eli Lilly Australia. 

________________________________________________________________________________________________________

 

Like our program?

Register for the 4 Corners of Cardiology Meeting 2020 by clicking the button below.

 

Join us in Melbourne

Key Dates

Meeting Dates:
7 – 8 February 2020

Expression of Interest

Complete the expression of interest form to receive updated information on the 5th International 4 Corners of Cardiology Meeting.

Share

Share Meeting information with delegates, speakers, Meeting organisers

Address for Communications


4CCardiology Meeting Managers
454 Collins Street
Melbourne VIC 3000
Telephone: +61 3 8888 9500

For all registration and accomodation enquiries
contact us on: register.4ccardiology@arinex.com.au

For all program and general enquiries contact us on: 4ccardiology@arinex.com.au